Digital rectal examination in prostate cancer screening at PSA level 3.0-3.9 ng/ml: long-term results from a randomized trial

Veera Soronena Faculty of Social Sciences, Tampere University, Tampere, FinlandCorrespondence[email protected]
View further author information

Kirsi Talalab Finnish Cancer Registry, Helsinki, FinlandView further author information

Jani Raitanena Faculty of Social Sciences, Tampere University, Tampere, Finland;c The UKK Institute for Health Promotion Research, Tampere, FinlandView further author information

Kimmo Taarid Medical Faculty, University of Helsinki, Helsinki, Finland;e Department of Urology, Helsinki University Hospital, Helsinki, FinlandView further author information

Teuvo Tammelaf Department of Urology, Tampere University Hospital, Tampere, Finland;g Faculty of Medicine and Life Sciences, Tampere University, Tampere, FinlandView further author information

Anssi Auvinena Faculty of Social Sciences, Tampere University, Tampere, FinlandView further author information

Digital rectal examination in prostate cancer screening at PSA level 3.0-3.9 ng/ml: long-term results from a randomized trial

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Digital rectal examination in prostate cancer screening at PSA level 3.0-3.9 ng/ml: long-term results from a randomized trial

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date